US0008991046
US0008991046
ADMA Biologics Inc
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 510.173.000 | 426.454.000 | 19.6% |
| Cost of Revenue | 217.408.000 | 206.901.000 | 5.1% |
| Gross Profit | 292.765.000 | 219.553.000 | 33.3% |
| 101.322.000 | 80.570.000 | 25.8% | |
| Operating Income | 191.443.000 | 138.983.000 | 37.7% |
| Pretax Income | 182.656.000 | 125.714.000 | 45.3% |
| Net Income Common Stockholders | 146.930.000 | 197.673.000 | 25.7% |
| -- | -- | -- | |
| -- | -- | -- |